Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Kansas City Urology Care is a private regional specialty medical group focused on urology, urologic oncology, and related men's health and pelvic health services in the Kansas City metropolitan area. The practice operates numerous clinic locations across Kansas and Missouri and provides office-based and hospital-based care, including diagnostics, surgery, radiation-related cancer care, and minimally invasive procedures. Its services include treatment for prostate, bladder, and kidney cancers as well as benign urologic conditions such as benign prostatic hyperplasia, stones, incontinence, and bladder dysfunction. KCUC highlights advanced treatment offerings such as robotic surgery, RapidArc radiotherapy, PROVENGE, Aquablation, Rezum, UroLift, InterStim neuromodulation, and other procedural therapies. The organization appears to function as a physician-led healthcare services provider rather than a drug-development biotech company.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Kansas City Urology Care.